Screener
Nurix Therapeutics, Inc. NRIX Internal research and development expenses — R&D
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | Three Months Ended May 31, 2026 | Three Months Ended May 31, 2025 | Six Months Ended May 31, 2026 | Six Months Ended May 31, 2025 |
|---|---|---|---|---|
| External clinical development expenses: | ||||
| Bexobrutideg (NX-5948) | $28,192 | $18,558 | $52,166 | $34,278 |
| Zelebrudomide (NX-2127) | 1,167 | 1,559 | 3,073 | 2,665 |
| NX-1607 | 1,738 | 2,332 | 2,926 | 4,292 |
| Internal research and development expenses | 56,556 | 55,647 | 113,624 | 106,524 |
| Total research and development expenses | $87,653 | $78,096 | $171,789 | $147,759 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s internal research and development expenses — R&D?
- Nurix Therapeutics, Inc. (NRIX) reported internal research and development expenses — R&D of $56.56M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s internal research and development expenses — R&D changed year-over-year?
- Nurix Therapeutics, Inc.'s internal research and development expenses — R&D increased by 1.6% year-over-year, from $55.65M to $56.56M.
- What does internal research and development expenses — R&D mean?
- This metric represents the total costs incurred by the company for internal research and development activities focused on the discovery and advancement of novel therapeutic candidates. It captures the investment in proprietary drug development programs, including preclinical studies and clinical trials, essential for building the company's pipeline. Monitoring this expenditure provides insight into the company's commitment to innovation and its long-term strategy for commercializing new medical treatments.
Ask your AI about Nurix Therapeutics, Inc.'s internal research and development expenses — r&d.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude